Performance Analysis of Gyroscope and Accelerometer Sensors for Seismocardiography-Based Wearable Pre-Ejection Period Estimation

A Flexible PVDF Sensor for Forcecardiography

Forcecardiography (FCG) uses force sensors to record the mechanical vibrations induced on the chest wall by cardiac and respiratory activities. FCG is usually performed via piezoelectric lead-zirconate titanate (PZT) sensors, which simultaneously record the very slow respiratory movements of the chest, the slow infrasonic vibrations due to emptying and filling of heart chambers, the faster infrasonic vibrations due to movements of heart valves, which are usually recorded via Seismocardiography (SCG), and the audible vibrations corresponding to heart sounds, commonly recorded via Phonocardiography (PCG). However, PZT sensors are not flexible and do not adapt very well to the deformations of soft tissues on the chest. This study presents a flexible FCG sensor based on a piezoelectric polyvinylidene fluoride (PVDF) transducer. The PVDF FCG sensor was compared with a well-assessed PZT FCG sensor, as well as with an electro-resistive respiratory band (ERB), an accelerometric SCG sensor, and an electronic stethoscope for PCG. Simultaneous recordings were acquired with these sensors and an electrocardiography (ECG) monitor from a cohort of 35 healthy subjects (16 males and 19 females). The PVDF sensor signals were compared in terms of morphology with those acquired simultaneously via the PZT sensor, the SCG sensor and the electronic stethoscope. Moreover, the estimation accuracies of PVDF and PZT sensors for inter-beat intervals (IBIs) and inter-breath intervals (IBrIs) were assessed against reference ECG and ERB measurements. The results of statistical analyses confirmed that the PVDF sensor provides FCG signals with very high similarity to those acquired via PZT sensors (median cross-correlation index of 0.96 across all subjects) as well as with SCG and PCG signals (median cross-correlation indices of 0.85 and 0.80, respectively). Moreover, the PVDF sensor provides very accurate estimates of IBIs, with R2 > 0.99 and Bland-Altman limits of agreement (LoA) of [-5.30; 5.00] ms, and of IBrIs, with R2 > 0.96 and LoA of [-0.510; 0.513] s. The flexibility of the PVDF sensor makes it more comfortable and ideal for wearable applications. Unlike PZT, PVDF is lead-free, which increases safety and biocompatibility for prolonged skin contact.

Cuffless Blood Pressure in clinical practice: challenges, opportunities and current limits

Background: Cuffless blood pressure measurement technologies have attracted significant attention for their potential to transform cardiovascular monitoring.Methods: This updated narrative review thoroughly examines the challenges, opportunities, and limitations associated with the implementation of cuffless blood pressure monitoring systems.Results: Diverse technologies, including photoplethysmography, tonometry, and ECG analysis, enable cuffless blood pressure measurement and are integrated into devices like smartphones and smartwatches. Signal processing emerges as a critical aspect, dictating the accuracy and reliability of readings. Despite its potential, the integration of cuffless technologies into clinical practice faces obstacles, including the need to address concerns related to accuracy, calibration, and standardization across diverse devices and patient populations. The development of robust algorithms to mitigate artifacts and environmental disturbances is essential for extracting clear physiological signals. Based on extensive research, this review emphasizes the necessity for standardized protocols, validation studies, and regulatory frameworks to ensure the reliability and safety of cuffless blood pressure monitoring devices and their implementation in mainstream medical practice. Interdisciplinary collaborations between engineers, clinicians, and regulatory bodies are crucial to address technical, clinical, and regulatory complexities during implementation. In conclusion, while cuffless blood pressure monitoring holds immense potential to transform cardiovascular care. The resolution of existing challenges and the establishment of rigorous standards are imperative for its seamless incorporation into routine clinical practice.Conclusion: The emergence of these new technologies shifts the paradigm of cardiovascular health management, presenting a new possibility for non-invasive continuous and dynamic monitoring. The concept of cuffless blood pressure measurement is viable and more finely tuned devices are expected to enter the market, which could redefine our understanding of blood pressure and hypertension.

A Residual U-Net Neural Network for Seismocardiogram Denoising and Analysis During Physical Activity

Seismocardiogram (SCG) signals are noninvasively obtained cardiomechanical signals containing important features for cardiovascular health monitoring. However, these signals are prone to contamination by motion noise, which can significantly impact accuracy and robustness of the measurements. A deep learning model based on the U-Net architecture is proposed to recover SCG signals contaminated by motion noise induced by walking. The model performance was evaluated through qualitative visualization, as well as quantitative analyses. Quantitative analyses included distance-based comparisons before and after applying our model. Analyses also included assessments of the model's efficacy in improving the performance of downstream tasks related to health parameter estimation during walking. Experimental findings revealed that the denoising model improved similarity to clean signals by approximately 90%. The performance of the model in enhancing heart rate estimation demonstrated a mean absolute error of 1.21 BPM and a root-mean-squared error (RMSE) of 1.97 BPM during walking after denoising with 9.16 BPM and 10.38 BPM improvements, respectively, compared to without denoising. Furthermore, the RMSEs of aortic opening and aortic closing time estimation after denoising for one dataset with catheter ground truth were 7.29 ms and 19.71 ms during walking, respectively, with 50.33 ms and 51.91 ms RMSE improvements compared to without denoising. And for another dataset with ICG-derived PEP ground truth, the RMSE of aortic opening time estimation after denoising was 10.21 ms during walking, with 38.74 ms RMSE improvement compared to without denoising. The proposed model attenuates motion noise from corrupted SCG signals while preserving cardiac information. This development paves the way for improved ambulatory cardiac health monitoring using wearable accelerometers during daily activities.

Smartphone-Based Recognition of Heart Failure by Means of Microelectromechanical Sensors

BACKGROUND

Heart failure (HF) is the leading cause of hospitalization in individuals over 65 years of age. Identifying noninvasive methods to detect HF may address the epidemic of HF. Seismocardiography which measures cardiac vibrations transmitted to the chest wall has recently emerged as a promising technology to detect HF.

OBJECTIVES

In this multicenter study, the authors examined whether seismocardiography using commercially available smartphones can differentiate control subjects from patients with stage C HF.

METHODS

Both inpatients and outpatients with HF were enrolled from Finland and the United States. Inpatients with HF were assessed within 2 days of admission, and outpatients were assessed in the ambulatory setting. In a prespecified pooled data analysis, algorithms were derived using logistic regression and then validated using a bootstrap aggregation method.

RESULTS

A total of 217 participants with HF (174 inpatients and 172 outpatients) and 786 control subjects from cardiovascular clinics were enrolled. The mean age of participants with acute HF was 64 ± 13 years, 64.9% were male, left ventricular ejection fraction was 39% ± 15%, and median N-terminal pro-B-type natriuretic peptide was 5,778 ng/L (Q1-Q3: 1,933-6,703). The majority (74%) of participants with HF had reduced EF, and 38% had atrial fibrillation. Across both HF cohorts, the algorithms had an area under the receiver operating characteristic curve of 0.95 with a sensitivity of 85%, specificity of 90%, and accuracy of 89% for the detection of HF, with a decision threshold of 0.5. The positive and negative likelihood ratios were 8.50 and 0.17, respectively. The accuracy of the algorithms was not significantly different in subgroups based on age, sex, body mass index, and atrial fibrillation.

CONCLUSIONS

Smartphone-based assessment of cardiac function using seismocardiography is feasible and differentiates patients with HF from control subjects with high diagnostic accuracy. (Recognition of Heart Failure With Micro Electro-mechanical Sensors FI; NCT04444583; Recognition of Heart Failure With Micro Electro-mechanical Sensors [NCT04378179]; Detection of Coronary Artery Disease With Micro Electro-mechanical Sensors; NCT04290091).

A Wavelet-Based Approach for Motion Artifact Reduction in Ambulatory Seismocardiography

Wearable sensing has become a vital approach to cardiac health monitoring, and seismocardiography (SCG) is emerging as a promising technology in this field. However, the applicability of SCG is hindered by motion artifacts, including those encountered in practice of which the strongest source is walking. This holds back the translation of SCG to clinical settings. We therefore investigated techniques to enhance the quality of SCG signals in the presence of motion artifacts. To simulate ambulant recordings, we corrupted a clean SCG dataset with real-walking-vibrational noise. We decomposed the signal using several empirical-mode-decomposition methods and the maximum overlap discrete wavelet transform (MODWT). By combining MODWT, time-frequency masking, and nonnegative matrix factorization, we developed a novel algorithm which leveraged the vertical axis accelerometer to reduce walking vibrations in dorsoventral SCG. The accuracy and applicability of our method was verified using heart rate estimation. We used an interactive selection approach to improve estimation accuracy. The best decomposition method for reduction of motion artifact noise was the MODWT. Our algorithm improved heart rate estimation from 0.1 to 0.8 r-squared at -15 dB signal-to-noise ratio (SNR). Our method reduces motion artifacts in SCG signals up to a SNR of -19 dB without requiring any external assistance from electrocardiography (ECG). Such a standalone solution is directly applicable to the usage of SCG in daily life, as a content-rich replacement for other wearables in clinical settings, and other continuous monitoring scenarios. In applications with higher noise levels, ECG may be incorporated to further enhance SCG and extend its usable range. This work addresses the challenges posed by motion artifacts, enabling SCG to offer reliable cardiovascular insights in more difficult scenarios, and thereby facilitating wearable monitoring in daily life and the clinic.

Wearable Devices in Cardiovascular Medicine

Wearable devices, such as smartwatches and activity trackers, are commonly used by patients in their everyday lives to manage their health and well-being. These devices collect and analyze long-term continuous data on measures of behavioral or physiologic function, which may provide clinicians with a more comprehensive view of a patients' health compared with the traditional sporadic measures captured by office visits and hospitalizations. Wearable devices have a wide range of potential clinical applications ranging from arrhythmia screening of high-risk individuals to remote management of chronic conditions such as heart failure or peripheral artery disease. As the use of wearable devices continues to grow, we must adopt a multifaceted approach with collaboration among all key stakeholders to effectively and safely integrate these technologies into routine clinical practice. In this Review, we summarize the features of wearable devices and associated machine learning techniques. We describe key research studies that illustrate the role of wearable devices in the screening and management of cardiovascular conditions and identify directions for future research. Last, we highlight the challenges that are currently hindering the widespread use of wearable devices in cardiovascular medicine and provide short- and long-term solutions to promote increased use of wearable devices in clinical care.

Thermal Calibration of Triaxial Accelerometer for Tilt Measurement

The application of MEMS accelerometers used to measure inclination is constrained by their temperature dependence, and each accelerometer needs to be calibrated individually to increase stability and accuracy. This paper presents a calibration and thermal compensation method for triaxial accelerometers that aims to minimize cost and processing time while maintaining high accuracy. First, the number of positions to perform the calibration procedure is optimized based on the Levenberg-Marquardt algorithm, and then, based on this optimized calibration number, thermal compensation is performed based on the least squares method, which is necessary for environments with large temperature variations, since calibration parameters change at different temperatures. The calibration procedures and algorithms were experimentally validated on marketed accelerometers. Based on the optimized calibration method, the calibrated results achieved nearly 100 times improvement. Thermal drift calibration experiments on the triaxial accelerometer show that the thermal compensation scheme in this paper can effectively reduce drift in the temperature range of -40 °C to 60 °C. The temperature drifts of x- and y-axes are reduced from -13.2 and 11.8 mg to -0.9 and -1.1 mg, respectively. The z-axis temperature drift is reduced from -17.9 to 1.8 mg. We have conducted various experiments on the proposed calibration method and demonstrated its capacity to calibrate the sensor frame error model (SFEM) parameters. This research proposes a new low-cost and efficient strategy for increasing the practical applicability of triaxial accelerometers.

Towards Wearable Estimation of Tidal Volume via Electrocardiogram and Seismocardiogram Signals

The current COVID-19 pandemic highlights the critical importance of ubiquitous respiratory health monitoring. The two fundamental elements of monitoring respiration are respiration rate (the frequency of breathing) and tidal volume (TV, the volume of air breathed by the lungs in each breath). Wearable sensing systems have been demonstrated to provide accurate measurement of respiration rate, but TV remains challenging to measure accurately with wearable and unobtrusive technology. In this work, we leveraged electrocardiogram (ECG) and seismocardiogram (SCG) measurements obtained with a custom wearable sensing patch to derive an estimate of TV from healthy human participants. Specifically, we fused both ECG-derived and SCG-derived respiratory signals (EDR and SDR) and trained a machine learning model with gas rebreathing as the ground truth to estimate TV. The respiration cycle modulates ECG and SCG signals in multiple different ways that are synergistic. Thus, here we extract EDRs and SDRs using a multitude of different demodulation techniques. The extracted features are used to train a subject independent machine learning model to accurately estimate TV. By fusing the extracted EDRs and SDRs, we were able to estimate the TV with a root-mean-square error (RMSE) of 181.45 mL and Pearson correlation coefficient (r) of 0.61, with a global subject-independent model. We further show that SDRs are better TV estimators than EDRs. Among SDRs, amplitude modulated (AM) SCG features are the most correlated to TV. We demonstrated that fusing EDRs and SDRs can result in moderately accurate estimation of TV using a subject-independent model. Additionally, we highlight the most informative features for estimating TV. This work presents a significant step towards achieving continuous, calibration free, and unobtrusive TV estimation, which could advance the state of the art in wearable respiratory monitoring.

Mechanocardiography in the Detection of Acute ST Elevation Myocardial Infarction: The MECHANO-STEMI Study

Novel means to minimize treatment delays in patients with ST elevation myocardial infarction (STEMI) are needed. Using an accelerometer and gyroscope on the chest yield mechanocardiographic (MCG) data. We investigated whether STEMI causes changes in MCG signals which could help to detect STEMI. The study group consisted of 41 STEMI patients and 49 control patients referred for elective coronary angiography and having normal left ventricular function and no valvular heart disease or arrhythmia. MCG signals were recorded on the upper sternum in supine position upon arrival to the catheterization laboratory. In this study, we used a dedicated wearable sensor equipped with 3-axis accelerometer, 3-axis gyroscope and 1-lead ECG in order to facilitate the detection of STEMI in a clinically meaningful way. A supervised machine learning approach was used. Stability of beat morphology, signal strength, maximum amplitude and its timing were calculated in six axes from each window with varying band-pass filters in 2-90 Hz range. In total, 613 features were investigated. Using logistic regression classifier and leave-one-person-out cross validation we obtained a sensitivity of 73.9%, specificity of 85.7% and AUC of 0.857 (SD = 0.005) using 150 best features. As a result, mechanical signals recorded on the upper chest wall with the accelerometers and gyroscopes differ significantly between STEMI patients and stable patients with normal left ventricular function. Future research will show whether MCG can be used for the early screening of STEMI.

Classification of Blood Volume Decompensation State via Machine Learning Analysis of Multi-Modal Wearable-Compatible Physiological Signals

This paper presents a novel computational algorithm to estimate blood volume decompensation state based on machine learning (ML) analysis of multi-modal wearable-compatible physiological signals. To the best of our knowledge, our algorithm may be the first of its kind which can not only discriminate normovolemia from hypovolemia but also classify hypovolemia into absolute hypovolemia and relative hypovolemia. We realized our blood volume classification algorithm by (i) extracting a multitude of features from multi-modal physiological signals including the electrocardiogram (ECG), the seismocardiogram (SCG), the ballistocardiogram (BCG), and the photoplethysmogram (PPG), (ii) constructing two ML classifiers using the features, one to classify normovolemia vs. hypovolemia and the other to classify hypovolemia into absolute hypovolemia and relative hypovolemia, and (iii) sequentially integrating the two to enable multi-class classification (normovolemia, absolute hypovolemia, and relative hypovolemia). We developed the blood volume decompensation state classification algorithm using the experimental data collected from six animals undergoing normovolemia, relative hypovolemia, and absolute hypovolemia challenges. Leave-one-subject-out analysis showed that our classification algorithm achieved an F1 score and accuracy of (i) 0.93 and 0.89 in classifying normovolemia vs. hypovolemia, (ii) 0.88 and 0.89 in classifying hypovolemia into absolute hypovolemia and relative hypovolemia, and (iii) 0.77 and 0.81 in classifying the overall blood volume decompensation state. The analysis of the features embedded in the ML classifiers indicated that many features are physiologically plausible, and that multi-modal SCG-BCG fusion may play an important role in achieving good blood volume classification efficacy. Our work may complement existing computational algorithms to estimate blood volume compensatory reserve as a potential decision-support tool to provide guidance on context-sensitive hypovolemia therapeutic strategy.

Estimation of Changes in Intracardiac Hemodynamics Using Wearable Seismocardiography and Machine Learning in Patients with Heart Failure: A Feasibility Study

OBJECTIVE

Tracking changes in hemodynamic congestion and the consequent proactive readjustment of treatment has shown efficacy in reducing hospitalizations for patients with heart failure (HF). However, the cost-prohibitive nature of these invasive sensing systems precludes their usage in the large patient population affected by HF. The objective of this research is to estimate the changes in pulmonary artery mean pressure (PAM) and pulmonary capillary wedge pressure (PCWP) following vasodilator infusion during right heart catheterization (RHC), using changes in simultaneously recorded wearable seismocardiogram (SCG) signals captured with a small wearable patch.

METHODS

A total of 20 patients with HF (20% women, median age 55 (interquartile range (IQR), 44-64) years, ejection fraction 24 (IQR, 16-43)) were fitted with a wearable sensing patch and underwent RHC with vasodilator challenge. We divided the dataset randomly into a trainingtesting set (n=15) and a separate validation set (n=5). We developed globalized (population) regression models to estimate changes in PAM and PCWP from the changes in simultaneously recorded SCG.

RESULTS

The regression model estimated both pressures with good accuracies: root-mean-square-error (RMSE) of 2.5 mmHg and R2 of 0.83 for estimating changes in PAM, and RMSE of 1.9 mmHg and R2 of 0.93 for estimating changes in PCWP for the training-testing set, and RMSE of 2.7 mmHg and R2 of 0.81 for estimating changes in PAM, and RMSE of 2.9 mmHg and R2 of 0.95 for estimating changes in PCWP for the validation set respectively.

CONCLUSION

Changes in wearable SCG signals may be used to track acute changes in intracardiac hemodynamics in patients with HF.

SIGNIFICANCE

This method holds promise in tracking longitudinal changes in hemodynamic congestion in hemodynamically-guided remote home monitoring and treatment for patients with HF.

Wearable Sensors and Machine Learning for Hypovolemia Problems in Occupational, Military and Sports Medicine: Physiological Basis, Hardware and Algorithms

Hypovolemia is a physiological state of reduced blood volume that can exist as either (1) absolute hypovolemia because of a lower circulating blood (plasma) volume for a given vascular space (dehydration, hemorrhage) or (2) relative hypovolemia resulting from an expanded vascular space (vasodilation) for a given circulating blood volume (e.g., heat stress, hypoxia, sepsis). This paper examines the physiology of hypovolemia and its association with health and performance problems common to occupational, military and sports medicine. We discuss the maturation of individual-specific compensatory reserve or decompensation measures for future wearable sensor systems to effectively manage these hypovolemia problems. The paper then presents areas of future work to allow such technologies to translate from lab settings to use as decision aids for managing hypovolemia. We envision a future that incorporates elements of the compensatory reserve measure with advances in sensing technology and multiple modalities of cardiovascular sensing, additional contextual measures, and advanced noise reduction algorithms into a fully wearable system, creating a robust and physiologically sound approach to manage physical work, fatigue, safety and health issues associated with hypovolemia for workers, warfighters and athletes in austere conditions.

At-home wireless monitoring of acute hemodynamic disturbances to detect sleep apnea and sleep stages via a soft sternal patch

Obstructive sleep apnea (OSA) affects more than 900 million adults globally and can create serious health complications when untreated; however, 80% of cases remain undiagnosed. Critically, current diagnostic techniques are fundamentally limited by low throughputs and high failure rates. Here, we report a wireless, fully integrated, soft patch with skin-like mechanics optimized through analytical and computational studies to capture seismocardiograms, electrocardiograms, and photoplethysmograms from the sternum, allowing clinicians to investigate the cardiovascular response to OSA during home sleep tests. In preliminary trials with symptomatic and control subjects, the soft device demonstrated excellent ability to detect blood-oxygen saturation, respiratory effort, respiration rate, heart rate, cardiac pre-ejection period and ejection timing, aortic opening mechanics, heart rate variability, and sleep staging. Last, machine learning is used to autodetect apneas and hypopneas with 100% sensitivity and 95% precision in preliminary at-home trials with symptomatic patients, compared to data scored by professionally certified sleep clinicians.

Analysis of Cardiac Vibration Signals Acquired From a Novel Implant Placed on the Gastric Fundus

The analysis of cardiac vibration signals has been shown as an interesting tool for the follow-up of chronic pathologies involving the cardiovascular system, such as heart failure (HF). However, methods to obtain high-quality, real-world and longitudinal data, that do not require the involvement of the patient to correctly and regularly acquire these signals, remain to be developed. Implantable systems may be a solution to this observability challenge. In this paper, we evaluate the feasibility of acquiring useful electrocardiographic (ECG) and accelerometry (ACC) data from an innovative implant located in the gastric fundus. In a first phase, we compare data acquired from the gastric fundus with gold standard data acquired from surface sensors on 2 pigs. A second phase investigates the feasibility of deriving useful hemodynamic markers from these gastric signals using data from 4 healthy pigs and 3 pigs with induced HF with longitudinal recordings. The following data processing chain was applied to the recordings: (1) ECG and ACC data denoising, (2) noise-robust real-time QRS detection from ECG signals and cardiac cycle segmentation, (3) Correlation analysis of the cardiac cycles and computation of coherent mean from aligned ECG and ACC, (4) cardiac vibration components segmentation (S1 and S2) from the coherent mean ACC data, and (5) estimation of signal context and a signal-to-noise ratio (SNR) on both signals. Results show a high correlation between the markers acquired from the gastric and thoracic sites, as well as pre-clinical evidence on the feasibility of chronic cardiovascular monitoring from an implantable cardiac device located at the gastric fundus, the main challenge remains on the optimization of the signal-to-noise ratio, in particular for the handling of some sources of noise that are specific to the gastric acquisition site.

A Novel Broadband Forcecardiography Sensor for Simultaneous Monitoring of Respiration, Infrasonic Cardiac Vibrations and Heart Sounds

The precordial mechanical vibrations generated by cardiac contractions have a rich frequency spectrum. While the lowest frequencies can be palpated, the higher infrasonic frequencies are usually captured by the seismocardiogram (SCG) signal and the audible ones correspond to heart sounds. Forcecardiography (FCG) is a non-invasive technique that measures these vibrations via force sensing resistors (FSR). This study presents a new piezoelectric sensor able to record all heart vibrations simultaneously, as well as a respiration signal. The new sensor was compared to the FSR-based one to assess its suitability for FCG. An electrocardiogram (ECG) lead and a signal from an electro-resistive respiration band (ERB) were synchronously acquired as references on six healthy volunteers (4 males, 2 females) at rest. The raw signals from the piezoelectric and the FSR-based sensors turned out to be very similar. The raw signals were divided into four components: Forcerespirogram (FRG), Low-Frequency FCG (LF-FCG), High-Frequency FCG (HF-FCG) and heart sounds (HS-FCG). A beat-by-beat comparison of FCG and ECG signals was carried out by means of regression, correlation and Bland–Altman analyses, and similarly for respiration signals (FRG and ERB). The results showed that the infrasonic FCG components are strongly related to the cardiac cycle (R² > 0.999, null bias and Limits of Agreement (LoA) of ± 4.9 ms for HF-FCG; R² > 0.99, null bias and LoA of ± 26.9 ms for LF-FCG) and the FRG inter-breath intervals are consistent with ERB ones (R² > 0.99, non-significant bias and LoA of ± 0.46 s). Furthermore, the piezoelectric sensor was tested against an accelerometer and an electronic stethoscope: synchronous acquisitions were performed to quantify the similarity between the signals. ECG-triggered ensemble averages (synchronized with R-peaks) of HF-FCG and SCG showed a correlation greater than 0.81, while those of HS-FCG and PCG scored a correlation greater than 0.85. The piezoelectric sensor demonstrated superior performances as compared to the FSR, providing more accurate, beat-by-beat measurements. This is the first time that a single piezoelectric sensor demonstrated the ability to simultaneously capture respiration, heart sounds, an SCG-like signal (i.e., HF-FCG) and the LF-FCG signal, which may provide information on ventricular emptying and filling events. According to these preliminary results the novel piezoelectric FCG sensor stands as a promising device for accurate, unobtrusive, long-term monitoring of cardiorespiratory functions and paves the way for a wide range of potential applications, both in the research and clinical fields. However, these results should be confirmed by further analyses on a larger cohort of subjects, possibly including also pathological patients.

A Comprehensive Review on Seismocardiogram: Current Advancements on Acquisition, Annotation, and Applications

In recent years, cardiovascular diseases are on the rise, and they entail enormous health burdens on global economies. Cardiac vibrations yield a wide and rich spectrum of essential information regarding the functioning of the heart, and thus it is necessary to take advantage of this data to better monitor cardiac health by way of prevention in early stages. Specifically, seismocardiography (SCG) is a noninvasive technique that can record cardiac vibrations by using new cutting-edge devices as accelerometers. Therefore, providing new and reliable data regarding advancements in the field of SCG, i.e., new devices and tools, is necessary to outperform the current understanding of the State-of-the-Art (SoTA). This paper reviews the SoTA on SCG and concentrates on three critical aspects of the SCG approach, i.e., on the acquisition, annotation, and its current applications. Moreover, this comprehensive overview also presents a detailed summary of recent advancements in SCG, such as the adoption of new techniques based on the artificial intelligence field, e.g., machine learning, deep learning, artificial neural networks, and fuzzy logic. Finally, a discussion on the open issues and future investigations regarding the topic is included.

Enabling Wearable Pulse Transit Time-Based Blood Pressure Estimation for Medically Underserved Areas and Health Equity: Comprehensive Evaluation Study

BACKGROUND

Noninvasive and cuffless approaches to monitor blood pressure (BP), in light of their convenience and accuracy, have paved the way toward remote screening and management of hypertension. However, existing noninvasive methodologies, which operate on mechanical, electrical, and optical sensing modalities, have not been thoroughly evaluated in demographically and racially diverse populations. Thus, the potential accuracy of these technologies in populations where they could have the greatest impact has not been sufficiently addressed. This presents challenges in clinical translation due to concerns about perpetuating existing health disparities.

OBJECTIVE

In this paper, we aim to present findings on the feasibility of a cuffless, wrist-worn, pulse transit time (PTT)-based device for monitoring BP in a diverse population.

METHODS

We recruited a diverse population through a collaborative effort with a nonprofit organization working with medically underserved areas in Georgia. We used our custom, multimodal, wrist-worn device to measure the PTT through seismocardiography, as the proximal timing reference, and photoplethysmography, as the distal timing reference. In addition, we created a novel data-driven beat-selection algorithm to reduce noise and improve the robustness of the method. We compared the wearable PTT measurements with those from a finger-cuff continuous BP device over the course of several perturbations used to modulate BP.

RESULTS

Our PTT-based wrist-worn device accurately monitored diastolic blood pressure (DBP) and mean arterial pressure (MAP) in a diverse population (N=44 participants) with a mean absolute difference of 2.90 mm Hg and 3.39 mm Hg for DBP and MAP, respectively, after calibration. Meanwhile, the mean absolute difference of our systolic BP estimation was 5.36 mm Hg, a grade B classification based on the Institute for Electronics and Electrical Engineers standard. We have further demonstrated the ability of our device to capture the commonly observed demographic differences in underlying arterial stiffness.

CONCLUSIONS

Accurate DBP and MAP estimation, along with grade B systolic BP estimation, using a convenient wearable device can empower users and facilitate remote BP monitoring in medically underserved areas, thus providing widespread hypertension screening and management for health equity.

Wearable Cuff-Less Blood Pressure Estimation at Home via Pulse Transit Time

OBJECTIVE

We developed a wearable watch-based device to provide noninvasive, cuff-less blood pressure (BP) estimation in an at-home setting.

METHODS

The watch measures single-lead electrocardiogram (ECG), tri-axial seismocardiogram (SCG), and multi-wavelength photoplethysmogram (PPG) signals to compute the pulse transit time (PTT), allowing for BP estimation. We sent our custom watch device and an oscillometric BP cuff home with 21 healthy subjects, and captured the natural variability in BP over the course of a 24-hour period.

RESULTS

After calibration, our Pearson correlation coefficient (PCC) of 0.69 and root-mean-square-error (RMSE) of 2.72 mmHg suggest that noninvasive PTT measurements correlate with around-the-clock BP. Using a novel two-point calibration method, we achieved a RMSE of 3.86 mmHg. We further demonstrated the potential of a semi-globalized adaptive model to reduce calibration requirements.

CONCLUSION

This is, to the best of our knowledge, the first time that BP has been comprehensively estimated noninvasively using PTT in an at-home setting. We showed a more convenient method for obtaining ambulatory BP than through the use of the standard oscillometric cuff. We presented new calibration methods for BP estimation using fewer calibration points that are more practical for a real-world scenario.

SIGNIFICANCE

A custom watch (SeismoWatch) capable of taking multiple BP measurements enables reliable remote monitoring of daily BP and paves the way towards convenient hypertension screening and management, which can potentially reduce hospitalizations and improve quality of life.

Non-Invasive Wearable Patch Utilizing Seismocardiography for Peri-Operative Use in Surgical Patients

OBJECTIVE

Optimizing peri-operative fluid management has been shown to improve patient outcomes and the use of stroke volume (SV) measurement has become an accepted tool to guide fluid therapy. The Transesophageal Doppler (TED) is a validated, minimally invasive device that allows clinical assessment of SV. Unfortunately, the use of the TED is restricted to the intra-operative setting in anesthetized patients and requires constant supervision and periodic adjustment for accurate signal quality. However, post-operative fluid management is also vital for improved outcomes. Currently, there is no device regularly used in clinics that can track patient's SV continuously and non-invasively both during and after surgery.

METHODS

In this paper, we propose the use of a wearable patch mounted on the mid-sternum, which captures the seismocardiogram (SCG) and electrocardiogram (ECG) signals continuously to predict SV in patients undergoing major surgery. In a study of 12 patients, hemodynamic data was recorded simultaneously using the TED and wearable patch. Signal processing and regression techniques were used to derive SV from the signals (SCG and ECG) captured by the wearable patch and compare it to values obtained by the TED.

RESULTS

The results showed that the combination of SCG and ECG contains substantial information regarding SV, resulting in a correlation and median absolute error between the predicted and reference SV values of 0.81 and 7.56 mL, respectively.

SIGNIFICANCE

This work shows promise for the proposed wearable-based methodology to be used as an alternative to TED for continuous patient monitoring and guiding peri-operative fluid management.

Chest-Worn Inertial Sensors: A Survey of Applications and Methods

Inertial Measurement Units (IMUs) are frequently implemented in wearable devices. Thanks to advances in signal processing and machine learning, applications of IMUs are not limited to those explicitly addressing body movements such as Activity Recognition (AR). On the other hand, wearing IMUs on the chest offers a few advantages over other body positions. AR and posture analysis, cardiopulmonary parameters estimation, voice and swallowing activity detection and other measurements can be approached through chest-worn inertial sensors. This survey tries to introduce the applications that come with the chest-worn IMUs and summarizes the existing methods, current challenges and future directions associated with them. In this regard, this paper references a total number of 57 relevant studies from the last 10 years and categorizes them into seven application areas. We discuss the inertial sensors used as well as their placement on the body and their associated validation methods based on the application categories. Our investigations show meaningful correlations among the studies within the same application categories. Then, we investigate the data processing architectures of the studies from the hardware point of view, indicating a lack of effort on handling the main processing through on-body units. Finally, we propose combining the discussed applications in a single platform, finding robust ways for artifact cancellation, and planning optimized sensing/processing architectures for them, to be taken more seriously in future research.

Estimation of Instantaneous Oxygen Uptake During Exercise and Daily Activities Using a Wearable Cardio-Electromechanical and Environmental Sensor

OBJECTIVE

To estimate instantaneous oxygen uptake VO₂ with a small, low-cost wearable sensor during exercise and daily activities in order to enable monitoring of energy expenditure (EE) in uncontrolled settings. We aim to do so using a combination of seismocardiogram (SCG), electrocardiogram (ECG) and atmospheric pressure (AP) signals obtained from a minimally obtrusive wearable device.

METHODS

In this study, subjects performed a treadmill protocol in a controlled environment and an outside walking protocol in an uncontrolled environment. During testing, the COSMED K5 metabolic system collected gold standard breath-by-breath (BxB) data and a custom-built wearable patch placed on the mid-sternum collected SCG, ECG and AP signals. We extracted features from these signals to estimate the BxB VO₂ data obtained from the COSMED system.

RESULTS

In estimating instantaneous VO₂, we achieved our best results on the treadmill protocol using a combination of SCG (frequency) and AP features (RMSE of 3.68 ± 0.98 ml/kg/min and R² of 0.77). For the outside protocol, we achieved our best results using a combination of SCG (frequency), ECG and AP features (RMSE of 4.3 ± 1.47 ml/kg/min and R² of 0.64). In estimating VO₂ consumed over one minute intervals during the protocols, our median percentage error was 15.8[Formula: see text] for the treadmill protocol and 20.5[Formula: see text] for the outside protocol.

CONCLUSION

SCG, ECG and AP signals from a small wearable patch can enable accurate estimation of instantaneous VO₂ in both controlled and uncontrolled settings. SCG signals capturing variation in cardio-mechanical processes, AP signals, and state of the art machine learning models contribute significantly to the accurate estimation of instantaneous VO₂.

SIGNIFICANCE

Accurate estimation of VO₂ with a low cost, minimally obtrusive wearable patch can enable the monitoring of VO₂ and EE in everyday settings and make the many applications of these measurements more accessible to the general public.

Feasibility of Heart Rate and Respiratory Rate Estimation by Inertial Sensors Embedded in a Virtual Reality Headset

Virtual reality (VR) headsets, with embedded micro-electromechanical systems, have the potential to assess the mechanical heart's functionality and respiratory activity in a non-intrusive way and without additional sensors by utilizing the ballistocardiographic principle. To test the feasibility of this approach for opportunistic physiological monitoring, thirty healthy volunteers were studied at rest in different body postures (sitting (SIT), standing (STAND) and supine (SUP)) while accelerometric and gyroscope data were recorded for 30 s using a VR headset (Oculus Go, Oculus, Microsoft, USA) simultaneously with a 1-lead electrocardiogram (ECG) signal for mean heart rate (HR) estimation. In addition, longer VR acquisitions (50 s) were performed under controlled breathing in the same three postures to estimate the respiratory rate (RESP). Three frequency-based methods were evaluated to extract from the power spectral density the corresponding frequency. By the obtained results, the gyroscope outperformed the accelerometer in terms of accuracy with the gold standard. As regards HR estimation, the best results were obtained in SIT, with Rs2 (95% confidence interval) = 0.91 (0.81-0.96) and bias (95% Limits of Agreement) -1.6 (5.4) bpm, followed by STAND, with Rs2= 0.81 (0.64-0.91) and -1.7 (11.6) bpm, and SUP, with Rs2 = 0.44 (0.15-0.68) and 0.2 (19.4) bpm. For RESP rate estimation, SUP showed the best feasibility (98%) to obtain a reliable value from each gyroscope axis, leading to the identification of the transversal direction as the one containing the largest breathing information. These results provided evidence of the feasibility of the proposed approach with a degree of performance and feasibility dependent on the posture of the subject, under the conditions of keeping the head still, setting the grounds for future studies in real-world applications of HR and RESP rate measurement through VR headsets.

Gyrocardiography: A Review of the Definition, History, Waveform Description, and Applications

Gyrocardiography (GCG) is a non-invasive technique of analyzing cardiac vibrations by a MEMS (microelectromechanical system) gyroscope placed on a chest wall. Although its history is short in comparison with seismocardiography (SCG) and electrocardiography (ECG), GCG becomes a technique which may provide additional insight into the mechanical aspects of the cardiac cycle. In this review, we describe the summary of the history, definition, measurements, waveform description and applications of gyrocardiography. The review was conducted on about 55 works analyzed between November 2016 and September 2020. The aim of this literature review was to summarize the current state of knowledge in gyrocardiography, especially the definition, waveform description, the physiological and physical sources of the signal and its applications. Based on the analyzed works, we present the definition of GCG as a technique for registration and analysis of rotational component of local cardiac vibrations, waveform annotation, several applications of the gyrocardiography, including, heart rate estimation, heart rate variability analysis, hemodynamics analysis, and classification of various cardiac diseases.

Cardiac Function Monitoring for Patients Undergoing Cancer Treatments Using Wearable Seismocardiography: A Proof-of-Concept Study

Advances in cancer therapeutics have dramatically improved the survival rate and quality of life in patients affected by various cancers, but have been accompanied by treatment-related cardiotoxicity, e.g. left ventricular (LV) dysfunction and/or overt heart failure (HF). Cardiologists thus need to assess cancer treatment-related cardiotoxic risks and have close followups for cancer survivors and patients undergoing cancer treatments using serial echocardiography exams and cardiovascular biomarkers testing. Unfortunately, the cost-prohibitive nature of echocardiography has made these routine follow-ups difficult and not accessible to the growing number of cancer survivors and patients undergoing cancer treatments. There is thus a need to develop a wearable system that can yield similar information at a minimal cost and can be used for remote monitoring of these patients. In this proof-of-concept study, we have investigated the use of wearable seismocardiography (SCG) to monitor LV function non-invasively for patients undergoing cancer treatment. A total of 12 subjects (six with normal LV relaxation, five with impaired relaxation and one with pseudo-normal relaxation) underwent routine echocardiography followed by a standard six-minute walk test. Wearable SCG and electrocardiogram signals were collected during the six-minute walk test and, later, the signal features were compared between subjects with normal and impaired LV relaxation. Pre-ejection period (PEP) from SCG decreased significantly (p < 0.05) during exercise for the subjects with impaired relaxation compared to the subjects with normal relaxation, and changes in PEP/LV ejection time (LVET) were also significantly different between these two groups (p < 0.05). These results suggest that wearable SCG may enable monitoring of patients undergoing cancer treatments by assessing cardiotoxicity.

Vital Sign Monitoring in Car Seats Based on Electrocardiography, Ballistocardiography and Seismocardiography: A Review

This paper focuses on a thorough summary of vital function measuring methods in vehicles. The focus of this paper is to summarize and compare already existing methods integrated into car seats with the implementation of inter alia capacitive electrocardiogram (cECG), mechanical motion analysis Ballistocardiography (BCG) and Seismocardiography (SCG). In addition, a comprehensive overview of other methods of vital sign monitoring, such as camera-based systems or steering wheel sensors, is also presented in this article. Furthermore, this work contains a very thorough background study on advanced signal processing methods and their potential application for the purpose of vital sign monitoring in cars, which is prone to various disturbances and artifacts occurrence that have to be eliminated.

Harnessing the Manifold Structure of Cardiomechanical Signals for Physiological Monitoring During Hemorrhage

OBJECTIVE

Local oscillation of the chest wall in response to events during the cardiac cycle may be captured using a sensing modality called seismocardiography (SCG), which is commonly used to infer cardiac time intervals (CTIs) such as the pre-ejection period (PEP). An important factor impeding the ubiquitous application of SCG for cardiac monitoring is that morphological variability of the signals makes consistent inference of CTIs a difficult task in the time-domain. The goal of this work is therefore to enable SCG-based physiological monitoring during trauma-induced hemorrhage using signal dynamics rather than morphological features.

METHODS

We introduce and explore the observation that SCG signals follow a consistent low-dimensional manifold structure during periods of changing PEP induced in a porcine model of trauma injury. Furthermore, we show that the distance traveled along this manifold correlates strongly to changes in PEP ( ∆PEP).

RESULTS

∆PEP estimation during hemorrhage was achieved with a median R² of 92.5% using a rapid manifold approximation method, comparable to an ISOMAP reference standard, which achieved an R² of 95.3%.

CONCLUSION

Rapidly approximating the manifold structure of SCG signals allows for physiological inference abstracted from the time-domain, laying the groundwork for robust, morphology-independent processing methods.

SIGNIFICANCE

Ultimately, this work represents an important advancement in SCG processing, enabling future clinical tools for trauma injury management.

Enabling the assessment of trauma-induced hemorrhage via smart wearable systems

As the leading cause of trauma-related mortality, blood loss due to hemorrhage is notoriously difficult to triage and manage. To enable timely and appropriate care for patients with trauma, this work elucidates the externally measurable physiological features of exsanguination, which were used to develop a globalized model for assessing blood volume status (BVS) or the relative severity of blood loss. These features were captured via both a multimodal wearable system and a catheter-based reference and used to accurately infer BVS in a porcine model of hemorrhage (n = 6). Ultimately, high-level features of cardiomechanical function were shown to strongly predict progression toward cardiovascular collapse and used to estimate BVS with a median error of 15.17 and 18.17% for the catheter-based and wearable systems, respectively. Exploring the nexus of biomedical theory and practice, these findings lay the groundwork for digital biomarkers of hemorrhage severity and warrant further study in human subjects.

Modeling Consistent Dynamics of Cardiogenic Vibrations in Low-Dimensional Subspace

The seismocardiogram (SCG) measures the movement of the chest wall in response to underlying cardiovascular events. Though this signal contains clinically-relevant information, its morphology is both patient-specific and highly transient. In light of recent work suggesting the existence of population-level patterns in SCG signals, the objective of this study is to develop a method which harnesses these patterns to enable robust signal processing despite morphological variability. Specifically, we introduce seismocardiogram generative factor encoding (SGFE), which models the SCG waveform as a stochastic sample from a low-dimensional subspace defined by a unified set of generative factors. We then demonstrate that during dynamic processes such as exercise-recovery, learned factors correlate strongly with known generative factors including aortic opening (AO) and closing (AC), following consistent trajectories in subspace despite morphological differences. Furthermore, we found that changes in sensor location affect the perceived underlying dynamic process in predictable ways, thereby enabling algorithmic compensation for sensor misplacement during generative factor inference. Mapping these trajectories to AO and AC yielded R2 values from 0.81-0.90 for AO and 0.72-0.83 for AC respectively across five sensor positions. Identification of consistent behavior of SCG signals in low dimensions corroborates the existence of population-level patterns in these signals; SGFE may also serve as a harbinger for processing methods that are abstracted from the time domain, which may ultimately improve the feasibility of SCG utilization in ambulatory and outpatient settings.

Investigating the estimation of cardiac time intervals using gyrocardiography

OBJECTIVE

Assessment of cardiac time intervals (CTIs) is essential for monitoring cardiac performance. Recently, gyrocardiography (GCG) has been introduced as a non-invasive technology for cardiac monitoring. GCG measures the chest's angular precordial vibrations caused by myocardium wall motion using a gyroscope sensor attached to the sternum. In this study, we investigated the accuracy and reproducibility of estimating CTIs from the GCG recordings of 50 adults.

APPROACH

We proposed five fiducial points for the GCG waveforms associated with the opening and closure of aortic and mitral valves. Two annotators annotated the suggested points on each cardiac cycle. The points were compared to the corresponding opening and closing of cardiac valves delineated on Tissue Doppler imaging (TDI) recordings. The fiducial points were annotated on seismocardiography (SCG) and impedance cardiography (ICG) signals recorded simultaneously.

MAIN RESULTS

For estimating the timing of mitral valve closure, aortic valve opening, aortic valve closure, and mitral valve opening, 40%, 67%, 75%, and 70% of GCG annotations fell in the corresponding echocardiography ranges, respectively. The results showed moderate-to-excellent (r = 0.4-0.92; p-value < 0.01) correlation between the measured and the reference CTls. A myocardial performance index (Tei index) adapted using joint GCG and SCG resulted in a moderate correlation (r = 0.4; p-value < 0.001).

SIGNIFICANCE

The findings showed that the CTIs can be easily measured using GCG. Also, we found that using SCG and GCG recordings together could provide an opportunity to estimate CTIs more accurately, and make it possible to calculate the Tei index as an indicator of myocardial performance.

A Unified Framework for Quality Indexing and Classification of Seismocardiogram Signals

The seismocardiogram (SCG) is a noninvasively-obtained cardiovascular bio-signal that has gained traction in recent years, however is limited by its susceptibility to noise and motion artifacts. Because of this, signal quality must be assured before data are used to inform clinical care. Common methods of signal quality assurance include signal classification or assignment of a numerical quality index. Such tasks are difficult with SCG because there is no accepted standard for signal morphology. In this paper, we propose a unified method of quality indexing and classification that uses multi-subject-based methods to overcome this challenge. Dynamic-time feature matching is introduced as a novel method of obtaining the distance between a signal and reference template, with this metric, the signal quality index (SQI) is defined as a function of the inverse distance between the SCG and a large set of template signals. We demonstrate that this method is able to stratify SCG signals on held-out subjects based on their level of motion-artifact corruption. This method is extended, using the SQI as a feature for classification by ensembled quadratic discriminant analysis. Classification is validated by demonstrating, for the first time, both detection and localization of SCG sensor misplacement, achieving an F1 score of 0.83 on held-out subjects. This paper may provide a necessary step toward automating the analysis of SCG signals, addressing many of the key limitations and concerns precluding the method from being widely used in clinical and physiological sensing applications.

Mechano-acoustic sensing of physiological processes and body motions via a soft wireless device placed at the suprasternal notch

Skin-mounted soft electronics incorporating high-bandwidth triaxial accelerometers can provide broad classes of physiologically relevant information, such as mechanoacoustic signatures of underlying body processes (such as those captured by a stethoscope) and precision kinematics of core body motions. Here, we describe a wireless device designed to be conformally placed on the suprasternal notch for the continuous measurement of mechanoacoustic signals, from subtle vibrations of the skin at accelerations of ~10⁻³ m·s⁻² to large motions of the entire body at ~10 m·s⁻², and at frequencies up to ~800 Hz. Because th measurements are a complex superposition of signals that arise from locomotion, body orientation, swallowing, respiration, cardiac activity, vocal-fold vibrations and other sources, we used frequency-domain analysis and machine learning to obtain, from human subjects during natural daily activities and exercise, real-time recordings of heart rate, respiration rate, energy intensity and other essential vital signs, as well as talking time and cadence, swallow counts and patterns, and other unconventional biomarkers. We also used the device in sleep laboratories, and validated the measurements via polysomnography.

A Globalized Model for Mapping Wearable Seismocardiogram Signals to Whole-Body Ballistocardiogram Signals Based on Deep Learning

The ballistocardiography (BCG) signal is a measurement of the vibrations of the center of mass of the body due to the cardiac cycle and can be used for noninvasive hemodynamic monitoring. The seismocardiography (SCG) signals measure the local vibrations of the chest wall due to the cardiac cycle. While BCG is a more well-known modality, it requires the use of a modified bathroom scale or a force plate and cannot be measured in a wearable setting, whereas SCG signals can be measured using wearable accelerometers placed on the sternum. In this paper, we explore the idea of finding a mapping between zero mean and unit l₂-norm SCG and BCG signal segments such that, the BCG signal can be acquired using wearable accelerometers (without retaining amplitude information). We use neural networks to find such a mapping and make use of the recently introduced UNet architecture. We trained our models on 26 healthy subjects and tested them on ten subjects. Our results show that we can estimate the aforementioned segments of the BCG signal with a median Pearson correlation coefficient of 0.71 and a median absolute deviation (MAD) of 0.17. Furthermore, our model can estimate the R-I, R-J and R-K timing intervals with median absolute errors (and MAD) of 10.00 (8.90), 6.00 (5.93), and 8.00 (5.93), respectively. We show that using all three axis of the SCG accelerometer produces the best results, whereas the head-to-foot SCG signal produces the best results when a single SCG axis is used.